COM:GRAVITONCORP
Graviton Bioscience Corporation
- Privately Held
locale
United States
market
PRIVATEindustry
Biotechnologywebsite
gravitoncorp.comcrunchbase
graviton-8c85linkedin
graviton-bioscience
Graviton develops novel therapeutics for the treatment of autoimmune, cancer, certain genetic, fibrotic, and other serious diseases. It is currently studying TDI01, a highly selective, potent inhibitor of Rho/Rho-associated coiled-coil containing protein kinase 2 (ROCK2) for the treatment of idiopathic pulmonary fibrosis (IPF) in the United States.